Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-058166
Filing Date
2023-11-02
Accepted
2023-11-02 16:05:34
Documents
56
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q mrus-20230930.htm   iXBRL 10-Q 2903934
2 EX-31.1 mrus-ex31_1.htm EX-31.1 18354
3 EX-31.2 mrus-ex31_2.htm EX-31.2 17930
4 EX-32.1 mrus-ex32_1.htm EX-32.1 16352
  Complete submission text file 0000950170-23-058166.txt   9383405

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mrus-20230930_cal.xml EX-101.CAL 48528
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mrus-20230930.xsd EX-101.SCH 41873
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mrus-20230930_def.xml EX-101.DEF 159420
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mrus-20230930_lab.xml EX-101.LAB 337251
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mrus-20230930_pre.xml EX-101.PRE 246282
50 EXTRACTED XBRL INSTANCE DOCUMENT mrus-20230930_htm.xml XML 1945341
Mailing Address YALELAAN 62 3584 CM UTRECHT P7 3584 CM
Business Address YALELAAN 62 3584 CM UTRECHT P7 3584 CM 31 030 253 8800
Merus N.V. (Filer) CIK: 0001651311 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37773 | Film No.: 231372191
SIC: 2834 Pharmaceutical Preparations